3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole and Attention Deficit Disorder with Hyperactivity

3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole has been researched along with Attention Deficit Disorder with Hyperactivity in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (12.50)	18.2507
2000's	4 (50.00)	29.6817
2010's	3 (37.50)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Calina, D; Martins, N; Peron, G; Rapposelli, S; Salehi, B; Sestito, S; Sharifi-Rad, J; Sharifi-Rad, M; Sharopov, F	1
Franke, AG; Huss, M; Konrad, A; Lieb, K	1
Guo, L; Guo, T; Liu, K; Yang, C	1
Biederman, J; Spencer, T	1
Decker, MW; Wilens, TE	1
Abrams, A; Biederman, J; Bostic, J; Fine, C; Monuteaux, MC; Polisner, D; Prince, J; Rater, M; Soriano, J; Spencer, TJ; Wilens, TE	1
Horrigan, JP	1
Bennani, YL; Black, LA; Decker, MW; Esbenshade, TA; Faghih, R; Fox, GB; Hancock, AA; Pan, JB	1

Reviews

4 review(s) available for 3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole and Attention Deficit Disorder with Hyperactivity

Article	Year
Epibatidine: A Promising Natural Alkaloid in Health. Biomolecules, 2018, 12-23, Volume: 9, Issue:1 Topics: Alkaloids; Analgesics; Attention Deficit Disorder with Hyperactivity; Bridged Bicyclo Compounds, Heterocyclic; Cytochrome P-450 Enzyme System; Humans; Isoxazoles; Neurodegenerative Diseases; Pyridines; Pyrrolidines; Quantum Theory; Receptors, Nicotinic	2018
[Stimulant and non-stimulant medication in current and future therapy for ADHD]. Fortschritte der Neurologie-Psychiatrie, 2012, Volume: 80, Issue:3 Topics: Adrenergic alpha-2 Receptor Agonists; Adult; Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Benzhydryl Compounds; Central Nervous System Stimulants; Child; Dextroamphetamine; Fatty Acids, Omega-3; Guanfacine; Histamine Agonists; Humans; Isoxazoles; Lisdexamfetamine Dimesylate; Memantine; Methylphenidate; Modafinil; Off-Label Use; Propylamines; Pyridines; Pyrrolidines; Receptors, AMPA	2012
Neuronal nicotinic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: focus on cognition. Biochemical pharmacology, 2007, Oct-15, Volume: 74, Issue:8 Topics: Animals; Attention Deficit Disorder with Hyperactivity; Cognition; Humans; Isoxazoles; Nicotinic Agonists; Pyridines; Pyrrolidines; Receptors, Nicotinic; Synaptic Transmission	2007
Present and future pharmacotherapeutic options for adult attention deficit/hyperactivity disorder. Expert opinion on pharmacotherapy, 2001, Volume: 2, Issue:4 Topics: Adult; Amphetamines; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Donepezil; Dopamine Plasma Membrane Transport Proteins; Humans; Indans; Isoxazoles; Membrane Glycoproteins; Membrane Transport Proteins; Methylphenidate; Nerve Tissue Proteins; Piperidines; Pyrrolidines	2001

Trials

1 trial(s) available for 3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole and Attention Deficit Disorder with Hyperactivity

Article	Year
A pilot controlled clinical trial of ABT-418, a cholinergic agonist, in the treatment of adults with attention deficit hyperactivity disorder. The American journal of psychiatry, 1999, Volume: 156, Issue:12 Topics: Administration, Cutaneous; Adult; Age Factors; Anti-Anxiety Agents; Attention Deficit Disorder with Hyperactivity; Cholinergic Agonists; Cross-Over Studies; Dizziness; Double-Blind Method; Female; Humans; Isoxazoles; Male; Nausea; Pilot Projects; Pyrrolidines; Treatment Outcome	1999

Article

Year

A pilot controlled clinical trial of ABT-418, a cholinergic agonist, in the treatment of adults with attention deficit hyperactivity disorder.

The American journal of psychiatry, 1999, Volume: 156, Issue:12

Topics: Administration, Cutaneous; Adult; Age Factors; Anti-Anxiety Agents; Attention Deficit Disorder with Hyperactivity; Cholinergic Agonists; Cross-Over Studies; Dizziness; Double-Blind Method; Female; Humans; Isoxazoles; Male; Nausea; Pilot Projects; Pyrrolidines; Treatment Outcome

1999

Other Studies

3 other study(ies) available for 3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole and Attention Deficit Disorder with Hyperactivity

Article	Year
A comparative study of the effects of ABT-418 and methylphenidate on spatial memory in an animal model of ADHD. Neuroscience letters, 2012, Oct-18, Volume: 528, Issue:1 Topics: Animals; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Disease Models, Animal; Immunohistochemistry; Isoxazoles; Male; Maze Learning; Memory; Methylphenidate; Nicotinic Agonists; Pyrrolidines; Rats; Rats, Inbred SHR; Receptors, Nicotinic	2012
Non-stimulant treatment for Attention-Deficit/Hyperactivity Disorder. Journal of attention disorders, 2002, Volume: 6 Suppl 1 Topics: Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Central Nervous System Agents; Child; Cholinesterase Inhibitors; Clinical Trials as Topic; Dopamine Agents; Humans; Isoxazoles; Nootropic Agents; Norepinephrine; Pyrrolidines; Treatment Outcome	2002
Effects of histamine H(3) receptor ligands GT-2331 and ciproxifan in a repeated acquisition avoidance response in the spontaneously hypertensive rat pup. Behavioural brain research, 2002, Apr-01, Volume: 131, Issue:1-2 Topics: Animals; Anti-Anxiety Agents; Arousal; Attention Deficit Disorder with Hyperactivity; Avoidance Learning; Central Nervous System Stimulants; Cognition Disorders; Disease Models, Animal; Histamine Antagonists; Imidazoles; Impulsive Behavior; Isoxazoles; Ligands; Male; Methylphenidate; Motor Activity; Nicotinic Agonists; Psychomotor Performance; Pyrrolidines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Histamine H3	2002